Clinical Trials Directory

Trials / Completed

CompletedNCT00384540

Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling

Allograft Vasculopathy After Heart Transplantation : Diagnostic Interest of Dobutamine Stress Echocardiography and Brain Natriuretic Peptide Coupling

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary purpose :To early detect cardiac allograft vasculopathy and to identify patients with high risk of cardiac events, by coupling the analysis of the kinetics of the brain natriuretic peptide ( BNP) with that of the left ventricle (LV) during a dobutamine stress echocardiography. Hypothesis : Plasma BNP elevation and abnormalities of LV kinetic during the ESD, will be associated with the presence of allograft vasculopathy and the arisen of cardiovascular events.

Conditions

Interventions

TypeNameDescription
PROCEDUREDobutamine stress echocardiography, coronarography, brachial arterial echographyDSE: cumulative doses of dobutamine (max = 40 µg/kg/min) and atropine (max = 1.5 mg), to reach a maximal heart rate under clinical, electrocardiographic and echocardiographic surveillancesCoronarography: invasive injection into coronary arteries of a radiological product showing a contrast visible on an x-ray. FMD: Flow-mediated dilatation of the brachial artery induced by 5-min forearm arterial occlusion

Timeline

Start date
2006-09-01
Primary completion
2015-11-22
Completion
2016-12-20
First posted
2006-10-06
Last updated
2018-07-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00384540. Inclusion in this directory is not an endorsement.